M. Papadopoulos

发表

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with 99mTc

P. Bouziotis, A. Chiotellis, M. Paravatou‐Petsotas, 2021, Nanomaterials.

Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety.

A. Chiotellis, M. Pelecanou, C. Tsoukalas, 2012, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Novel oxorhenium and oxotechnetium MO(NS)(S)2 complexes in the development of 5-HT1A receptor imaging agents.

E. Chiotellis, A. Terzis, C. Raptopoulou, 2003, Journal of inorganic biochemistry.

Synthesis and characterization of five-coordinate rhenium(V) and technetium(V) mixed ligand bifunctional complexes carrying the SNS/S or the SNN/S donor atom set. Crystal structure of ReO{[(C2H5)2NCH2CH2N(CH2CH2S)2](p-H2N–PhS)} and ReO{[(CH2)4NCH2CH2NCH2CH2S](p-H2N–PhS)}

E. Chiotellis, A. Terzis, C. Raptopoulou, 1999 .

Synthesis, characterization and evaluation of 68Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor.

K. Kopka, P. Bouziotis, M. Pelecanou, 2020, Bioorganic chemistry.

Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.

G. Makris, D. Papagiannopoulou, I. Vizirianakis, 2016, Molecular pharmaceutics.

Crystal structure of fac-tricarbonyl(quinoline-2-carboxylato-κ2 N,O)(triphenylarsane-κAs)rhenium(I)

V. Psycharis, C. Raptopoulou, M. Pelecanou, 2016, Acta crystallographica. Section E, Crystallographic communications.

New labeled derivatives of the neuroprotective peptide colivelin: synthesis, characterization, and first in vitro and in vivo applications.

D. Benaki, H. Boleti, M. Sagnou, 2015, Archives of biochemistry and biophysics.

In vitro binding and in vivo biodistribution studies of the neuroprotective peptide humanin using [125I]humanin derivatives

D. Benaki, J. Slaninová, P. Bouziotis, 2009, Peptides.

Biological evaluation of complexes of cyclopentadienyl M(CO)3+ (M = Re, 99mTc) with high blood–brain barrier penetration potential as brain cancer agents

A. Kaminari, P. Bouziotis, M. Sagnou, 2022, Investigational New Drugs.

Electrospray ionization study of tricarbonyl fac-[Re(CO)3 (PO)(X)]-type complexes: influence of ancillary co-ligands in the release of carbon monoxide.

P. Traldi, R. Seraglia, F. Tisato, 2018, Rapid communications in mass spectrometry : RCM.

New 99mTc(CO)3(NNO) complexes in the development of 5HT1A receptor imaging agents

A. Chiotellis, M. Pelecanou, M. Papadopoulos, 2011 .

A ‘preformed chelate approach’ model for coupling amine-modified rhenium and technetium ‘3+1’ mixed ligand complexes to carboxylate residues

E. Chiotellis, A. Terzis, C. Raptopoulou, 1999 .

Rhenium(I) Tricarbonyl Complexes with (2-Hydroxyphenyl)diphenylphosphine as PO Bidentate Ligand.

V. Psycharis, C. Raptopoulou, F. Tisato, 2017, Inorganic chemistry.

Synthesis, structural characterization and radiochemistry of di- and tricarbonyl Re(I) and 99mTc(I) complexes with 8-hydroxyquinoline or 8-mercaptoquinoline and triphenylphosphine

A. Terzis, V. Psycharis, C. Raptopoulou, 2014 .

Renal elimination of some 99mTc-labelled cysteamine derivatives.

E. Chiotellis, M. Papadopoulos, S. Mansur, 1993, Nuclear medicine and biology.

Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system.

E. Chiotellis, A. Terzis, P. Bouziotis, 2001, Chemistry.

STUDY ON THE FORMATION OF MIXED LIGAND OXORHENIUM AND OXOTECHNETIUM COMPLEXES (SNS/S COMBINATION)

M. Friebe, E. Chiotellis, C. Raptopoulou, 1999 .

SYNTHESIS, STRUCTURE, LIPOPHILICITY AND PROTONATION BEHAVIOUR OF MIXED LIGAND RHENIUM CHELATES FUNCTIONALIZED BY AMINE GROUPS

M. Friebe, E. Chiotellis, C. Raptopoulou, 1998 .

Comparative Study of a Series of 99mTc(CO)3 Mannosylated Dextran Derivatives for Sentinel Lymph Node Detection

G. Loudos, M. Pelecanou, A. Shegani, 2021, Molecules.

Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.

H. Pietzsch, M. Pelecanou, S. Fernández, 2013, Cancer biotherapy & radiopharmaceuticals.

New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection.

J. Correia, A. Yamaguchi, T. Uehara, 2012, Molecular pharmaceutics.

In vivo biodistribution and imaging studies with a 99mTc‐radiolabeled derivative of the C‐terminus of prothymosin alpha in mice bearing experimentally‐induced inflammation

G. Loudos, O. Tsitsilonis, H. Kalbacher, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils.

O. Tsitsilonis, Christos Liolios, H. Kalbacher, 2015, International journal of pharmaceutics.

Solid‐phase Synthesis of a Peptide Derivative of Thymosin alpha1 and Initial Studies on its 99mTc‐Radiolabelling

O. Tsitsilonis, W. Voelter, A. Beck, 2007, Chemical biology & drug design.

Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP

V. Psycharis, C. Raptopoulou, A. Chiotellis, 2022, Bioinorganic chemistry and applications.

Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.

Y. Tsushima, A. Yamaguchi, H. Hanaoka, 2015, Molecular pharmaceutics.

Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection.

S. Subramanian, G. Samuel, M. Venkatesh, 2012, Cancer biotherapy & radiopharmaceuticals.

O-((Ferrocenyl)(3-fluorophenyl)methyl)hydroxylamine

A. Chiotellis, Angeliki-Sofia Foscolos, M. Papadopoulos, 2022, Molbank.

Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

G. Loudos, H. Kiaris, E. Gourni, 2010, Journal of medicinal chemistry.

Neutral fac-[Re(NNN)(CO)3] complexes with NNN tridentate ligands containing pyrrole or indole

V. Psycharis, C. Raptopoulou, M. Pelecanou, 2016 .

Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M = Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

G. Patsis, E. Livaniou, M. Pelecanou, 2006, Journal of medicinal chemistry.

Synthesis and structural characterization of the [2,9-dimethyl-4,7-diaza-2,9-decanedithiolato]oxorhenium(V) complex

E. Chiotellis, C. Raptopoulou, M. Pelecanou, 1998 .

Synthesis and structure of oxotechnetium(V) complexes of N,N′ -ethylenebis(acetylacetone thioimine) and N,N′ -ethylenebis(benzylacetone thioimine)

E. Chiotellis, A. Terzis, M. Papadopoulos, 1991 .

Synthesis, characterization and biological evaluation of a novel "3 + 1" mixed ligand 99mTc complex having an aliphatic thiol as coligand.

E. Chiotellis, C. Raptopoulou, A. Rey, 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Synthesis and structural characterization of neutral 3 + 2 oxorhenium and oxotechnetium complexes of the 2 -mercaptoethyl -N -glycine (SNO)/2,2' -bipyridine (NN) mixed ligand system

D. Benaki, A. Terzis, C. Raptopoulou, 2007 .

Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.

A. Terzis, C. Raptopoulou, M. Pelecanou, 2006, Inorganic chemistry.

(S)-(2-(2'-Pyridyl)ethyl)cysteamine and (S)-(2-(2'-pyridyl)ethyl)-d,l-homocysteine as ligands for the "fac-[M(CO)(3)](+)" (M = Re, (99m)Tc) core.

A. Terzis, C. Raptopoulou, R. Alberto, 2005, Inorganic chemistry.

Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.

E. Chiotellis, A. Terzis, C. Raptopoulou, 1994, Journal of medicinal chemistry.

Glutathione-mediated metabolism of technetium-99m SNS/S mixed ligand complexes: a proposed mechanism of brain retention.

D. Yannoukakos, E. Chiotellis, B. Nock, 1999, Journal of medicinal chemistry.

Syn-Anti Isomerism in a Mixed-Ligand Oxorhenium Complex, ReO[SN(R)S][S].

E. Chiotellis, A. Terzis, C. Raptopoulou, 1996, Inorganic chemistry.

Structural studies of ReO(V) mixed ligand [SNS][Cl] and [SNS][S] complexes

E. Chiotellis, A. Terzis, C. Raptopoulou, 1999 .

Synthesis, structural characterization and radiochemistry of ‘‘2 + 1’’ fac-[99mTc/Re(CO)3(L)(2-mercaptopyridine)] complexes, where L is phosphine or isocyanide

V. Vassiliadis, A. Terzis, V. Psycharis, 2014 .

A new tricarbonyl fac-[M(acac)(isc)(CO)3] complex (M = Re, 99mTc) with acetylacetonate (acac) and isocyanide (isc) in a 2+1 combination

A. Terzis, C. Raptopoulou, M. Sagnou, 2010 .

Dicarbonyl cis-[M(CO)2(N,O)(C)(P)] (M = Re, 99mTc) Complexes with a New [2 + 1 + 1] Donor Atom Combination.

V. Psycharis, C. Raptopoulou, M. Pelecanou, 2018, Inorganic chemistry.

Synthesis and X‐ray structure determination of N,N′‐bis‐l‐(1‐carboxy‐2‐mercaptoethyl)ethylenediamine, oxotechnetium (V), [TcO(EC)]

E. Chiotellis, A. Terzis, C. Raptopoulou, 1994 .

Synthesis and characterization of novel "3 + 2" oxorhenium complexes, ReO[SNO][NN].

E. Chiotellis, A. Terzis, C. Raptopoulou, 2006, Inorganic chemistry.

Novel Six-Coordinate Oxorhenium “3 + 2” Mixed-Ligand Complexes Carrying the SNS/PO Donor Atom Set: Synthesis and Characterization

E. Chiotellis, F. Tisato, B. Nock, 1999 .

Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents.

E. Chiotellis, A. Terzis, C. Raptopoulou, 2002, Nuclear medicine and biology.

A New Donor Atom System [(SNN)(S)] for the Synthesis of Neutral Oxotechnetium(V) Mixed-Ligand Complexes.

E. Chiotellis, C. Raptopoulou, M. Pelecanou, 1996, Inorganic chemistry.

Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology.

A. Azqueta, A. López de Cerain, A. Monge, 2006, European journal of medicinal chemistry.

Synthesis and characterization of fac-[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)2(OO)] complexes (M = Re, (99m)Tc) with acetylacetone and curcumin as OO donor bidentate ligands.

A. Terzis, V. Psycharis, C. Raptopoulou, 2013, Inorganic chemistry.

A new bifunctional tridentate NSN ligand leading to cationic tricarbonyl fac-[M(NSN)(CO)3]+ (M = Re, 99mTc) complexes

A. Terzis, C. Raptopoulou, G. Patsis, 2013 .

A mixed-ligand P,S,N-cis-dioxorhenium(V) complex by ligand exchange reactions on trans-monooxo-trichlorobis(triphenylphosphine)rhenium(V): formation and structural studies

R. Jankowsky, M. Friebe, E. Chiotellis, 1998 .

First example of well-characterized Re and 99mTc tricarbonyl complexes of ciprofloxacin and norfloxacin in the development of infection-specific imaging agents

A. Terzis, C. Raptopoulou, D. Papagiannopoulou, 2011 .

Synthesis and characterization of mixed-ligand oxorhenium complexes with the SNN type of ligand. Isolation of a novel ReO[SN][S][S] complex.

E. Chiotellis, A. Terzis, C. Raptopoulou, 2000, Inorganic chemistry.

Simultaneous determination of paraquat and atrazine in water samples with a white light reflectance spectroscopy biosensor.

K. Misiakos, I. Raptis, D. Goustouridis, 2018, Journal of hazardous materials.

Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.

C. Raptopoulou, G. Patsis, H. Cerecetto, 2008, European journal of medicinal chemistry.

Parameters optimization defined by statistical analysis for cysteine-dextran radiolabeling with technetium tricarbonyl core.

N. G. da Silva, R. Pasqualini, A. Duatti, 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Rhenium(I) and technetium-99m(I) fac-tricarbonyl complexes with 4-(imidazolin-2-yl)-3-thiabutanoic acid derivatives as tridentate ligands: Synthesis and structural characterization

C. Raptopoulou, D. Papagiannopoulou, N. Nikolic, 2009 .

Complexes of an Alpha Thymosin Derivative with 185/187Re and 99mTc: Structural Analysis and Initial Biological Evaluation

O. Tsitsilonis, L. Leondiadis, D. Benaki, 2012, Chemical biology & drug design.

Mitochondrial D-loop Sequence Variability in Three Native Insular Griffon Vulture (Gyps fulvus) Populations from the Mediterranean Basin

P. Mereu, G. Frongia, G. Leoni, 2019, BioMed research international.

Design, Synthesis, Structural Optimization, SAR, in silico Prediction of Physicochemical Properties and Pharmacological Evaluation of Novel & Potent Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists

G. Liapakis, H. Fahmy, F. Fronczek, 2021, European Journal of Pharmaceutical Sciences.

Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.

S. Triantopoulou, H. Pietzsch, M. Pelecanou, 2022, Bioorganic & medicinal chemistry.

Models of poisoning effects on vulture populations show that small but frequent episodes have a larger effect than large but rare ones

K. Stara, R. Tsiakiris, J. Halley, 2021, Web Ecology.

Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting.

D. Papagiannopoulou, M. Akrivou, I. Vizirianakis, 2018, Nuclear medicine and biology.

Interaction of [ReO(SNS) (S)] and [99mTcO(SNS) (S)] mixed ligand complexes with glutathione: isolation and characterization of the product

E. Chiotellis, B. Nock, M. Pelecanou, 1998 .

Cysteine Derivatized 99mTc-Labelled Fatty Acids as β-Oxidation Markers

D. Psimadas, M. Pelecanou, C. Kiritsis, 2019, Inorganics.

Indium-111-labelled cationic complexes of aminothiols: structure-activity correlation

E. Chiotellis, A. Varvarigou, M. Papadopoulos, 1993, European Journal of Nuclear Medicine.

99mTc-DADT complexes substituted with heterocyclic amines: effect of substitution on in vivo reactivity.

E. Chiotellis, A. Varvarigou, M. Papadopoulos, 1993, Nuclear medicine and biology.

Correlation of lipophilicity to biodistribution of 99mTc-labelled aminothiols.

E. Chiotellis, A. Varvarigou, M. Papadopoulos, 1993, Nuclear medicine and biology.

A Phenylbenzothiazole Conjugate with the Tricarbonyl fac‐[M(I)(CO)3]+ (M = Re, 99Tc, 99mTc) Core for Imaging of β‐Amyloid Plaques

V. Psycharis, C. Raptopoulou, R. Alberto, 2012 .

Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imaging.

H. Pietzsch, A. Bourkoula, E. Livaniou, 2009, European journal of medicinal chemistry.

Convenient route leading to neutral fac-M(CO)3(NNO) complexes (M = Re, 99mTc) coupled to amine pharmacophores.

A. Terzis, C. Raptopoulou, A. Chiotellis, 2008, Inorganic chemistry.

Histidine derivatives as tridentate chelators for the fac-[MI(CO)3] (Re, 99mTc, 188Re) core: Synthesis, structural characterization, radiochemistry and stability

L. Leondiadis, V. Psycharis, C. Raptopoulou, 2011 .

Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.

G. Loudos, G. Patsis, E. Gourni, 2013, Bioorganic & medicinal chemistry.

Rhenium(I) and Technetium(I) Tricarbonyl Complexes with [NSO]‐Type Chelators: Synthesis, Structural Characterization, and Radiochemistry

A. Terzis, V. Psycharis, C. Raptopoulou, 2012 .

Rhenium(I) and technetium(I) fac-M(NSO)(CO)3 (M = Re, 99mTc) tricarbonyl complexes, with a tridentate NSO bifunctional agent: Synthesis, structural characterization, and radiochemistry

A. Terzis, C. Raptopoulou, G. Makris, 2010 .

Curcumin as the OO bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications.

D. Benaki, V. Psycharis, C. Raptopoulou, 2011, Inorganic chemistry.

Remarkable Brain Penetration of Cyclopentadienyl M(CO)3+ (M = 99mTc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer's Disease.

V. Psycharis, C. Raptopoulou, M. Sagnou, 2019, Journal of medicinal chemistry.

Crystal structure of fac-tricarbonyl(cyclohexyl isocyanide-κC)(quinoline-2-carboxylato-κ2 N,O)rhenium(I)

V. Psycharis, C. Raptopoulou, M. Pelecanou, 2016, Acta crystallographica. Section E, Crystallographic communications.

Mixed pharmacophore fac-[M(OO)(isc)(CO)3] (M = Re, 99mTc) complexes

M. Sagnou, M. Pelecanou, M. Paravatou‐Petsotas, 2014 .

Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents

S. Triantopoulou, A. Chiotellis, M. Pelecanou, 2023, Molecules.

A Bombesin Copper Complex Based on a Bifunctional Cyclam Derivative

N. Ioannidis, D. Benaki, Christos Liolios, 2012 .

Pentavalent rhenium-188 dimercaptosuccinic acid: a new kit formulation and its initial evaluation in mice

E. Chiotellis, P. Bouziotis, M. Papadopoulos, 2001 .

A new 153Sm bone seeking agent for potential use in pain palliation

E. Chiotellis, P. Bouziotis, A. Varvarigou, 2001 .

New 99mTc(CO)3 mannosylated dextrans bearing S-derivatized cysteine chelator

J. Correia, I. Santos, M. Pelecanou, 2010 .

Ester-modified 99mTcO[SN(R)S/S] mixed ligand complexes: synthesis and preliminary evaluation.

E. Chiotellis, C. Raptopoulou, C. Tsoukalas, 2001, Nuclear medicine and biology.

Synthesis and structural characterization of two cis-dioxorhenium(V) ReO2[SN][P] mixed-ligand complexes

M. Friebe, E. Chiotellis, A. Terzis, 2001 .

Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligand.

E. Chiotellis, A. Terzis, C. Raptopoulou, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and characterization of six-coordinate "3 + 2" mixed-ligand oxorhenium complexes with the o-diphenylphosphinophenolato ligand and tridentate coligands of different N and S donor atom combinations.

E. Chiotellis, C. Raptopoulou, F. Tisato, 2000, Inorganic chemistry.

Preparation and biodistribution of a technetium cationic complex - [TcIII(sacac)2en(PPh3)2]+

E. Chiotellis, A. Varvarigou, M. Papadopoulos, 1993 .

Spectroscopic Study of Oxotechnetium (V) Complexes with Thiominato Ligands in Solution

E. Chiotellis, E. Mikros, M. Papadopoulos, 1991 .

Oxotechnetium and Oxorhenium 3+1 Mixed Ligand Complexes as Potential Melanoma Targeting Agents

J. Chabalgoity, J. Giglio, A. Rey, 2005 .

Prothymosin Alpha: An Alarmin and More...

O. Tsitsilonis, H. Kalbacher, P. Samara, 2017, Current medicinal chemistry.

2-(4'-Aminophenyl)benzothiazole Labeled with 99mTc-Cyclopentadienyl for Imaging β-Amyloid Plaques.

G. Loudos, M. Sagnou, M. Pelecanou, 2017, ACS medicinal chemistry letters.

New labeled derivatives of the neuroprotective peptide colivelin: synthesis, characterization, and first in vitro and in vivo applications.

D. Benaki, H. Boleti, M. Sagnou, 2015, Archives of biochemistry and biophysics.

Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents

E. Chiotellis, A. Terzis, C. Raptopoulou, 2001, JBIC Journal of Biological Inorganic Chemistry.

Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.

E. Chiotellis, M. Papadopoulos, I. Pirmettis, 1997, Journal of medicinal chemistry.

Synthesis and Characterization of Oxotechnetium(V) Mixed-Ligand Complexes Containing a Tridentate N-Substituted Bis(2-mercaptoethyl)amine and a Monodentate Thiol.

E. Chiotellis, A. Terzis, C. Raptopoulou, 1996, Inorganic chemistry.